CL

Colgate-Palmolive Company

CLConsumer DefensiveNASDAQ

Household & Personal Products · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$20.38B
+1.4% YoY
Net Income
$2.13B
-26.2% YoY
EBITDA
$3.96B
-18.5% YoY
Free Cash Flow
$3.46B

Scan Results

Daily timeframe
10 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 76.4, above 70, stock may be overbought
Oct 19CONFIRMED▼ RSI OverboughtRSI 80.4, above 70, stock may be overbought
About Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. With a market capitalization of $74.97B, it sits in large-cap territory. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition.

Where CL stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, CL finished 5.61% above its 150-day moving average ($88.43) and 5.54% above its 200-day moving average ($88.49). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CL overbought or oversold?

At the October 20, 2026 close, CL's RSI(14) was 76.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$74.97B
P/E (TTM)37.02
Fwd P/E23.01
EPS$2.54
Beta0.32
52W Change+20.8%
Dividend Yield2.25%
ROE267.4%
Analysis

Colgate-Palmolive Company carries $7.86B in total debt against $1.45B in cash reserves — debt is roughly 5.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $3.46B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 267.4% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 15.8% further supports the picture of efficient asset utilization. Revenue has been uneven over recent years, ranging from $17.97B to $20.38B.

The relatively low beta of 0.32 suggests CL is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CL.

Links
More Consumer Defensive stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms